Please assess the completion status of the following clinical trial:

Trial Title: Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically or cytologically confirmed recurrent ovarian epithelial cancer after first line chemotherapy, unless clear evidence of clinically progressive disease~* Must have received prior first line chemotherapy consisting of at least 4 courses of either cisplatin or carboplatin~  * At least 12 months since prior chemotherapy~* Measurable disease by clinical exam or diagnostic laparoscopy~  * At least one lesion greater than 1 cm in diameter~* No leptomeningeal or brain metastases~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* WHO 0-2~Life expectancy:~* Not specified~Hematopoietic:~* Absolute neutrophil count greater than 1,500/mm\^3~* Platelet count greater than 100,000/mm\^3~Hepatic:~* Bilirubin less than 1.25 times upper limit of normal (ULN)~* SGPT less than 2 times ULN~Renal:~* Creatinine less than 1.6 mg/dL OR~* Creatinine clearance greater than 40 mL/min~Other:~* No peripheral neurotoxicity greater than grade 2~* No psychological, familial, sociological, or geographical condition that would preclude study~* No complete bowel obstruction~* No other malignancy except adequately treated basal cell skin cancer or carcinoma in situ of the cervix~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* No more than 1 prior regimen of chemotherapy~Endocrine therapy:~* Not specified~Radiotherapy:~* Not specified~Surgery:~* See Disease Characteristics

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).